These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26479945)

  • 21. Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidones.
    Boyd HF; Fell SC; Hickey DM; Ife RJ; Leach CA; Macphee CH; Milliner KJ; Pinto IL; Rawlings DA; Smith SA; Stansfield IG; Stanway SJ; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2002 Jan; 12(1):51-5. PubMed ID: 11738571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents.
    Ma LY; Zheng YC; Wang SQ; Wang B; Wang ZR; Pang LP; Zhang M; Wang JW; Ding L; Li J; Wang C; Hu B; Liu Y; Zhang XD; Wang JJ; Wang ZJ; Zhao W; Liu HM
    J Med Chem; 2015 Feb; 58(4):1705-16. PubMed ID: 25610955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
    Zhou N; Moradei O; Raeppel S; Leit S; Frechette S; Gaudette F; Paquin I; Bernstein N; Bouchain G; Vaisburg A; Jin Z; Gillespie J; Wang J; Fournel M; Yan PT; Trachy-Bourget MC; Kalita A; Lu A; Rahil J; MacLeod AR; Li Z; Besterman JM; Delorme D
    J Med Chem; 2008 Jul; 51(14):4072-5. PubMed ID: 18570366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties.
    Ren L; Laird ER; Buckmelter AJ; Dinkel V; Gloor SL; Grina J; Newhouse B; Rasor K; Hastings G; Gradl SN; Rudolph J
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1165-8. PubMed ID: 22196124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
    Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein-associated phospholipase A2.
    McConnell JP; Hoefner DM
    Clin Lab Med; 2006 Sep; 26(3):679-97, vii. PubMed ID: 16938590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of imidazole vinyl pyrimidines as a novel class of kinase inhibitors which inhibit Tie-2 and are orally bioavailable.
    Buttar D; Edge M; Emery SC; Fitzek M; Forder C; Griffen A; Hayter B; Hayward CF; Hopcroft PJ; Luke RW; Page K; Stawpert J; Wright A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4723-6. PubMed ID: 18676144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.
    Debenham JS; Madsen-Duggan C; Clements MJ; Walsh TF; Kuethe JT; Reibarkh M; Salowe SP; Sonatore LM; Hajdu R; Milligan JA; Visco DM; Zhou D; Lingham RB; Stickens D; DeMartino JA; Tong X; Wolff M; Pang J; Miller RR; Sherer EC; Hale JJ
    J Med Chem; 2016 Dec; 59(24):11039-11049. PubMed ID: 28002958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.
    Genin MJ; Gonzalez Valcarcel IC; Holloway WG; Lamar J; Mosior M; Hawkins E; Estridge T; Weidner J; Seng T; Yurek D; Adams LA; Weller J; Reynolds VL; Brozinick JT
    J Med Chem; 2016 Jun; 59(12):5904-10. PubMed ID: 27213958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors.
    McKenna JM; Halley F; Souness JE; McLay IM; Pickett SD; Collis AJ; Page K; Ahmed I
    J Med Chem; 2002 May; 45(11):2173-84. PubMed ID: 12014955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Clinical Candidate (1
    Kumar S; Waldo JP; Jaipuri FA; Marcinowicz A; Van Allen C; Adams J; Kesharwani T; Zhang X; Metz R; Oh AJ; Harris SF; Mautino MR
    J Med Chem; 2019 Jul; 62(14):6705-6733. PubMed ID: 31264862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentiviral-mediated RNA interference of lipoprotein-associated phospholipase A2 ameliorates inflammation and atherosclerosis in apolipoprotein E-deficient mice.
    Zhang H; Zhang J; Shen D; Zhang L; He F; Dang Y; Li L
    Int J Mol Med; 2013 Mar; 31(3):651-9. PubMed ID: 23338278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.
    Park EJ; Ahn YG; Jung SH; Bang HJ; Kim M; Hong DJ; Kim J; Suh KH; Kim YJ; Kim D; Kim EY; Lee K; Min KH
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4271-5. PubMed ID: 25082126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2).
    Lin EC; Hu Y; Amantea CM; Pham LM; Cajica J; Okerberg E; Brown HE; Fraser A; Du L; Kohno Y; Ishiyama J; Kozarich JW; Shreder KR
    Bioorg Med Chem Lett; 2012 Jan; 22(2):868-71. PubMed ID: 22217870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors.
    Xin M; Wen J; Tang F; Tu C; Shen H; Zhao X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6777-83. PubMed ID: 24176396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors.
    Zificsak CA; Theroff JP; Aimone LD; Angeles TS; Albom MS; Cheng M; Mesaros EF; Ott GR; Quail MR; Underiner TL; Wan W; Dorsey BD
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3877-80. PubMed ID: 21632243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.
    Boschelli DH; Wu Z; Klutchko SR; Showalter HD; Hamby JM; Lu GH; Major TC; Dahring TK; Batley B; Panek RL; Keiser J; Hartl BG; Kraker AJ; Klohs WD; Roberts BJ; Patmore S; Elliott WL; Steinkampf R; Bradford LA; Hallak H; Doherty AM
    J Med Chem; 1998 Oct; 41(22):4365-77. PubMed ID: 9784112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A
    Huiban M; Coello C; Wu K; Xu Y; Lewis Y; Brown AP; Buraglio M; Guan C; Shabbir S; Fong R; Passchier J; Rabiner EA; Lockhart A
    Mol Imaging Biol; 2017 Feb; 19(1):153-161. PubMed ID: 27402093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of imidazo[1,5-c]imidazol-3-ones: weakly basic, orally active factor Xa inhibitors.
    Imaeda Y; Kuroita T; Sakamoto H; Kawamoto T; Tobisu M; Konishi N; Hiroe K; Kawamura M; Tanaka T; Kubo K
    J Med Chem; 2008 Jun; 51(12):3422-36. PubMed ID: 18507371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.
    Bennett F; Kezar HS; Girijavallabhan V; Huang Y; Huelgas R; Rossman R; Shih NY; Piwinski JJ; MacCoss M; Kwong CD; Clark JL; Fowler AT; Geng F; Roychowdhury A; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Li C; Chase R; Curry S; Huang HC; Tong X; George Njoroge F; Arasappan A
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5144-9. PubMed ID: 22814211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.